Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by tdon1229on Nov 23, 2024 2:06pm
132 Views
Post# 36327505

RE:Laser tech question

RE:Laser tech questionIt's y understanding Theralse does not manufacture their lasers, but they work with others to produce the according to theralase specs.  As demand ramps up, I suspect the company will obtain competitive bids as necessary in order to provide fulfillment.  In the past they've worked closely with one company.  

Previous pricing for their Model 3200 green light laser resulted in a market price of $1600 or so.  The model they're using in this clinical trial is the prototypical 3300 which has a variable power setting and, I believe, a variable frequency setting. 

Others on here who have more details please feel free to add and/or correct what I've noted.  I'm old and committed these details to memory some years ago.  I'm sure there have been tweaks during the course of Study II.
<< Previous
Bullboard Posts
Next >>